ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drugs for Central Nervous System Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-25S2546
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
COVID 19 Impact on Drugs for Central Nervous System Market Global Research Reports 2020 2021
BUY CHAPTERS

Global Drugs for Central Nervous System Market Research Report 2024

Code: QYRE-Auto-25S2546
Report
January 2024
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Biogen
Pfizer Inc
TEVA
Johnson & Johnson
EliLilly
Otsuka
Merck
Astrazeneca plc
Takeda
Novartis

Drugs for Central Nervous System Market Size

The global Drugs for Central Nervous System market was valued at US$ 115260 million in 2023 and is anticipated to reach US$ 186780 million by 2030, witnessing a CAGR of 7.5% during the forecast period 2024-2030.

Drugs for Central Nervous System Market

Drugs for Central Nervous System Market

The central nervous system (CNS) is the part of thenervous system consisting of the brain and spinal cord. In this report, we study the drugs for central nervous system disease.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drugs for Central Nervous System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Central Nervous System.

Report Scope

The Drugs for Central Nervous System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drugs for Central Nervous System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs for Central Nervous System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Drugs for Central Nervous System Market Report

Report Metric Details
Report Name Drugs for Central Nervous System Market
Accounted market size in 2023 US$ 115260 million
Forecasted market size in 2030 US$ 186780 million
CAGR 7.5%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • OTC
  • Rx Drugs
Segment by Application
  • Hospital
  • Retail Pharmacy
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Biogen, Pfizer, Teva, Novartis, Johnson & Johnson, EliLilly, Otsuka, Merck, AstraZeneca, Takeda
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Drugs for Central Nervous System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Drugs for Central Nervous System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Drugs for Central Nervous System Market growing?

Ans: The Drugs for Central Nervous System Market witnessing a CAGR of 7.5% during the forecast period 2024-2030.

What is the Drugs for Central Nervous System Market size in 2030?

Ans: The Drugs for Central Nervous System Market size in 2030 will be US$ 186780 million.

Who are the main players in the Drugs for Central Nervous System Market report?

Ans: The main players in the Drugs for Central Nervous System Market are Biogen, Pfizer, Teva, Novartis, Johnson & Johnson, EliLilly, Otsuka, Merck, AstraZeneca, Takeda

What are the Application segmentation covered in the Drugs for Central Nervous System Market report?

Ans: The Applications covered in the Drugs for Central Nervous System Market report are Hospital, Retail Pharmacy

What are the Type segmentation covered in the Drugs for Central Nervous System Market report?

Ans: The Types covered in the Drugs for Central Nervous System Market report are OTC, Rx Drugs

1 Drugs for Central Nervous System Market Overview
1.1 Product Overview and Scope of Drugs for Central Nervous System
1.2 Drugs for Central Nervous System Segment by Type
1.2.1 Global Drugs for Central Nervous System Market Value Comparison by Type (2024-2030)
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Drugs for Central Nervous System Segment by Application
1.3.1 Global Drugs for Central Nervous System Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Global Drugs for Central Nervous System Market Size Estimates and Forecasts
1.4.1 Global Drugs for Central Nervous System Revenue 2019-2030
1.4.2 Global Drugs for Central Nervous System Sales 2019-2030
1.4.3 Global Drugs for Central Nervous System Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Drugs for Central Nervous System Market Competition by Manufacturers
2.1 Global Drugs for Central Nervous System Sales Market Share by Manufacturers (2019-2024)
2.2 Global Drugs for Central Nervous System Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Drugs for Central Nervous System Average Price by Manufacturers (2019-2024)
2.4 Global Drugs for Central Nervous System Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drugs for Central Nervous System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drugs for Central Nervous System, Product Type & Application
2.7 Drugs for Central Nervous System Market Competitive Situation and Trends
2.7.1 Drugs for Central Nervous System Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Drugs for Central Nervous System Players Market Share by Revenue
2.7.3 Global Drugs for Central Nervous System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drugs for Central Nervous System Retrospective Market Scenario by Region
3.1 Global Drugs for Central Nervous System Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Drugs for Central Nervous System Global Drugs for Central Nervous System Sales by Region: 2019-2030
3.2.1 Global Drugs for Central Nervous System Sales by Region: 2019-2024
3.2.2 Global Drugs for Central Nervous System Sales by Region: 2025-2030
3.3 Global Drugs for Central Nervous System Global Drugs for Central Nervous System Revenue by Region: 2019-2030
3.3.1 Global Drugs for Central Nervous System Revenue by Region: 2019-2024
3.3.2 Global Drugs for Central Nervous System Revenue by Region: 2025-2030
3.4 North America Drugs for Central Nervous System Market Facts & Figures by Country
3.4.1 North America Drugs for Central Nervous System Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Drugs for Central Nervous System Sales by Country (2019-2030)
3.4.3 North America Drugs for Central Nervous System Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Drugs for Central Nervous System Market Facts & Figures by Country
3.5.1 Europe Drugs for Central Nervous System Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Drugs for Central Nervous System Sales by Country (2019-2030)
3.5.3 Europe Drugs for Central Nervous System Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drugs for Central Nervous System Market Facts & Figures by Country
3.6.1 Asia Pacific Drugs for Central Nervous System Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Drugs for Central Nervous System Sales by Country (2019-2030)
3.6.3 Asia Pacific Drugs for Central Nervous System Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Drugs for Central Nervous System Market Facts & Figures by Country
3.7.1 Latin America Drugs for Central Nervous System Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Drugs for Central Nervous System Sales by Country (2019-2030)
3.7.3 Latin America Drugs for Central Nervous System Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drugs for Central Nervous System Market Facts & Figures by Country
3.8.1 Middle East and Africa Drugs for Central Nervous System Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Drugs for Central Nervous System Sales by Country (2019-2030)
3.8.3 Middle East and Africa Drugs for Central Nervous System Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drugs for Central Nervous System Sales by Type (2019-2030)
4.1.1 Global Drugs for Central Nervous System Sales by Type (2019-2024)
4.1.2 Global Drugs for Central Nervous System Sales by Type (2025-2030)
4.1.3 Global Drugs for Central Nervous System Sales Market Share by Type (2019-2030)
4.2 Global Drugs for Central Nervous System Revenue by Type (2019-2030)
4.2.1 Global Drugs for Central Nervous System Revenue by Type (2019-2024)
4.2.2 Global Drugs for Central Nervous System Revenue by Type (2025-2030)
4.2.3 Global Drugs for Central Nervous System Revenue Market Share by Type (2019-2030)
4.3 Global Drugs for Central Nervous System Price by Type (2019-2030)
5 Segment by Application
5.1 Global Drugs for Central Nervous System Sales by Application (2019-2030)
5.1.1 Global Drugs for Central Nervous System Sales by Application (2019-2024)
5.1.2 Global Drugs for Central Nervous System Sales by Application (2025-2030)
5.1.3 Global Drugs for Central Nervous System Sales Market Share by Application (2019-2030)
5.2 Global Drugs for Central Nervous System Revenue by Application (2019-2030)
5.2.1 Global Drugs for Central Nervous System Revenue by Application (2019-2024)
5.2.2 Global Drugs for Central Nervous System Revenue by Application (2025-2030)
5.2.3 Global Drugs for Central Nervous System Revenue Market Share by Application (2019-2030)
5.3 Global Drugs for Central Nervous System Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Biogen
6.1.1 Biogen Corporation Information
6.1.2 Biogen Description and Business Overview
6.1.3 Biogen Drugs for Central Nervous System Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Biogen Drugs for Central Nervous System Product Portfolio
6.1.5 Biogen Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Drugs for Central Nervous System Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Drugs for Central Nervous System Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Drugs for Central Nervous System Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Teva Drugs for Central Nervous System Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Drugs for Central Nervous System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Drugs for Central Nervous System Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Corporation Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Drugs for Central Nervous System Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Johnson & Johnson Drugs for Central Nervous System Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 EliLilly
6.6.1 EliLilly Corporation Information
6.6.2 EliLilly Description and Business Overview
6.6.3 EliLilly Drugs for Central Nervous System Sales, Revenue and Gross Margin (2019-2024)
6.6.4 EliLilly Drugs for Central Nervous System Product Portfolio
6.6.5 EliLilly Recent Developments/Updates
6.7 Otsuka
6.6.1 Otsuka Corporation Information
6.6.2 Otsuka Description and Business Overview
6.6.3 Otsuka Drugs for Central Nervous System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Otsuka Drugs for Central Nervous System Product Portfolio
6.7.5 Otsuka Recent Developments/Updates
6.8 Merck
6.8.1 Merck Corporation Information
6.8.2 Merck Description and Business Overview
6.8.3 Merck Drugs for Central Nervous System Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Merck Drugs for Central Nervous System Product Portfolio
6.8.5 Merck Recent Developments/Updates
6.9 AstraZeneca
6.9.1 AstraZeneca Corporation Information
6.9.2 AstraZeneca Description and Business Overview
6.9.3 AstraZeneca Drugs for Central Nervous System Sales, Revenue and Gross Margin (2019-2024)
6.9.4 AstraZeneca Drugs for Central Nervous System Product Portfolio
6.9.5 AstraZeneca Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Corporation Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Drugs for Central Nervous System Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Novartis Drugs for Central Nervous System Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Takeda
6.11.1 Takeda Corporation Information
6.11.2 Takeda Drugs for Central Nervous System Description and Business Overview
6.11.3 Takeda Drugs for Central Nervous System Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Takeda Drugs for Central Nervous System Product Portfolio
6.11.5 Takeda Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drugs for Central Nervous System Industry Chain Analysis
7.2 Drugs for Central Nervous System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drugs for Central Nervous System Production Mode & Process
7.4 Drugs for Central Nervous System Sales and Marketing
7.4.1 Drugs for Central Nervous System Sales Channels
7.4.2 Drugs for Central Nervous System Distributors
7.5 Drugs for Central Nervous System Customers
8 Drugs for Central Nervous System Market Dynamics
8.1 Drugs for Central Nervous System Industry Trends
8.2 Drugs for Central Nervous System Market Drivers
8.3 Drugs for Central Nervous System Market Challenges
8.4 Drugs for Central Nervous System Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Biogen
Pfizer Inc
TEVA
Johnson & Johnson
EliLilly
Otsuka
Merck
Astrazeneca plc
Takeda
Novartis
List of Tables
    Table 1. Global Drugs for Central Nervous System Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Drugs for Central Nervous System Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Drugs for Central Nervous System Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Drugs for Central Nervous System Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Drugs for Central Nervous System Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Drugs for Central Nervous System Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Drugs for Central Nervous System Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Drugs for Central Nervous System Average Price (USD/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Drugs for Central Nervous System, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Drugs for Central Nervous System, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Drugs for Central Nervous System, Product Type & Application
    Table 12. Global Key Manufacturers of Drugs for Central Nervous System, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Drugs for Central Nervous System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Central Nervous System as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Drugs for Central Nervous System Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Drugs for Central Nervous System Sales by Region (2019-2024) & (K Units)
    Table 18. Global Drugs for Central Nervous System Sales Market Share by Region (2019-2024)
    Table 19. Global Drugs for Central Nervous System Sales by Region (2025-2030) & (K Units)
    Table 20. Global Drugs for Central Nervous System Sales Market Share by Region (2025-2030)
    Table 21. Global Drugs for Central Nervous System Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Drugs for Central Nervous System Revenue Market Share by Region (2019-2024)
    Table 23. Global Drugs for Central Nervous System Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Drugs for Central Nervous System Revenue Market Share by Region (2025-2030)
    Table 25. North America Drugs for Central Nervous System Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Drugs for Central Nervous System Sales by Country (2019-2024) & (K Units)
    Table 27. North America Drugs for Central Nervous System Sales by Country (2025-2030) & (K Units)
    Table 28. North America Drugs for Central Nervous System Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Drugs for Central Nervous System Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Drugs for Central Nervous System Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Drugs for Central Nervous System Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Drugs for Central Nervous System Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Drugs for Central Nervous System Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Drugs for Central Nervous System Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Drugs for Central Nervous System Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Drugs for Central Nervous System Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Drugs for Central Nervous System Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Drugs for Central Nervous System Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Drugs for Central Nervous System Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Drugs for Central Nervous System Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Drugs for Central Nervous System Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Drugs for Central Nervous System Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Drugs for Central Nervous System Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Drugs for Central Nervous System Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Drugs for Central Nervous System Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Drugs for Central Nervous System Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Drugs for Central Nervous System Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Drugs for Central Nervous System Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Drugs for Central Nervous System Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Drugs for Central Nervous System Sales (K Units) by Type (2019-2024)
    Table 51. Global Drugs for Central Nervous System Sales (K Units) by Type (2025-2030)
    Table 52. Global Drugs for Central Nervous System Sales Market Share by Type (2019-2024)
    Table 53. Global Drugs for Central Nervous System Sales Market Share by Type (2025-2030)
    Table 54. Global Drugs for Central Nervous System Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Drugs for Central Nervous System Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Drugs for Central Nervous System Revenue Market Share by Type (2019-2024)
    Table 57. Global Drugs for Central Nervous System Revenue Market Share by Type (2025-2030)
    Table 58. Global Drugs for Central Nervous System Price (USD/Unit) by Type (2019-2024)
    Table 59. Global Drugs for Central Nervous System Price (USD/Unit) by Type (2025-2030)
    Table 60. Global Drugs for Central Nervous System Sales (K Units) by Application (2019-2024)
    Table 61. Global Drugs for Central Nervous System Sales (K Units) by Application (2025-2030)
    Table 62. Global Drugs for Central Nervous System Sales Market Share by Application (2019-2024)
    Table 63. Global Drugs for Central Nervous System Sales Market Share by Application (2025-2030)
    Table 64. Global Drugs for Central Nervous System Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Drugs for Central Nervous System Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Drugs for Central Nervous System Revenue Market Share by Application (2019-2024)
    Table 67. Global Drugs for Central Nervous System Revenue Market Share by Application (2025-2030)
    Table 68. Global Drugs for Central Nervous System Price (USD/Unit) by Application (2019-2024)
    Table 69. Global Drugs for Central Nervous System Price (USD/Unit) by Application (2025-2030)
    Table 70. Biogen Corporation Information
    Table 71. Biogen Description and Business Overview
    Table 72. Biogen Drugs for Central Nervous System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 73. Biogen Drugs for Central Nervous System Product
    Table 74. Biogen Recent Developments/Updates
    Table 75. Pfizer Corporation Information
    Table 76. Pfizer Description and Business Overview
    Table 77. Pfizer Drugs for Central Nervous System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 78. Pfizer Drugs for Central Nervous System Product
    Table 79. Pfizer Recent Developments/Updates
    Table 80. Teva Corporation Information
    Table 81. Teva Description and Business Overview
    Table 82. Teva Drugs for Central Nervous System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 83. Teva Drugs for Central Nervous System Product
    Table 84. Teva Recent Developments/Updates
    Table 85. Novartis Corporation Information
    Table 86. Novartis Description and Business Overview
    Table 87. Novartis Drugs for Central Nervous System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 88. Novartis Drugs for Central Nervous System Product
    Table 89. Novartis Recent Developments/Updates
    Table 90. Johnson & Johnson Corporation Information
    Table 91. Johnson & Johnson Description and Business Overview
    Table 92. Johnson & Johnson Drugs for Central Nervous System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 93. Johnson & Johnson Drugs for Central Nervous System Product
    Table 94. Johnson & Johnson Recent Developments/Updates
    Table 95. EliLilly Corporation Information
    Table 96. EliLilly Description and Business Overview
    Table 97. EliLilly Drugs for Central Nervous System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 98. EliLilly Drugs for Central Nervous System Product
    Table 99. EliLilly Recent Developments/Updates
    Table 100. Otsuka Corporation Information
    Table 101. Otsuka Description and Business Overview
    Table 102. Otsuka Drugs for Central Nervous System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 103. Otsuka Drugs for Central Nervous System Product
    Table 104. Otsuka Recent Developments/Updates
    Table 105. Merck Corporation Information
    Table 106. Merck Description and Business Overview
    Table 107. Merck Drugs for Central Nervous System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 108. Merck Drugs for Central Nervous System Product
    Table 109. Merck Recent Developments/Updates
    Table 110. AstraZeneca Corporation Information
    Table 111. AstraZeneca Description and Business Overview
    Table 112. AstraZeneca Drugs for Central Nervous System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 113. AstraZeneca Drugs for Central Nervous System Product
    Table 114. AstraZeneca Recent Developments/Updates
    Table 115. Novartis Corporation Information
    Table 116. Novartis Description and Business Overview
    Table 117. Novartis Drugs for Central Nervous System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 118. Novartis Drugs for Central Nervous System Product
    Table 119. Novartis Recent Developments/Updates
    Table 120. Takeda Corporation Information
    Table 121. Takeda Description and Business Overview
    Table 122. Takeda Drugs for Central Nervous System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 123. Takeda Drugs for Central Nervous System Product
    Table 124. Takeda Recent Developments/Updates
    Table 125. Key Raw Materials Lists
    Table 126. Raw Materials Key Suppliers Lists
    Table 127. Drugs for Central Nervous System Distributors List
    Table 128. Drugs for Central Nervous System Customers List
    Table 129. Drugs for Central Nervous System Market Trends
    Table 130. Drugs for Central Nervous System Market Drivers
    Table 131. Drugs for Central Nervous System Market Challenges
    Table 132. Drugs for Central Nervous System Market Restraints
    Table 133. Research Programs/Design for This Report
    Table 134. Key Data Information from Secondary Sources
    Table 135. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Drugs for Central Nervous System
    Figure 2. Global Drugs for Central Nervous System Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Drugs for Central Nervous System Market Share by Type in 2023 & 2030
    Figure 4. OTC Product Picture
    Figure 5. Rx Drugs Product Picture
    Figure 6. Global Drugs for Central Nervous System Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Drugs for Central Nervous System Market Share by Application in 2023 & 2030
    Figure 8. Hospital
    Figure 9. Retail Pharmacy
    Figure 10. Global Drugs for Central Nervous System Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 11. Global Drugs for Central Nervous System Market Size (2019-2030) & (US$ Million)
    Figure 12. Global Drugs for Central Nervous System Sales (2019-2030) & (K Units)
    Figure 13. Global Drugs for Central Nervous System Average Price (USD/Unit) & (2019-2030)
    Figure 14. Drugs for Central Nervous System Report Years Considered
    Figure 15. Drugs for Central Nervous System Sales Share by Manufacturers in 2023
    Figure 16. Global Drugs for Central Nervous System Revenue Share by Manufacturers in 2023
    Figure 17. The Global 5 and 10 Largest Drugs for Central Nervous System Players: Market Share by Revenue in 2023
    Figure 18. Drugs for Central Nervous System Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 19. Global Drugs for Central Nervous System Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 20. North America Drugs for Central Nervous System Sales Market Share by Country (2019-2030)
    Figure 21. North America Drugs for Central Nervous System Revenue Market Share by Country (2019-2030)
    Figure 22. the United States Drugs for Central Nervous System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 23. Canada Drugs for Central Nervous System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Europe Drugs for Central Nervous System Sales Market Share by Country (2019-2030)
    Figure 25. Europe Drugs for Central Nervous System Revenue Market Share by Country (2019-2030)
    Figure 26. Germany Drugs for Central Nervous System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. France Drugs for Central Nervous System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. UK Drugs for Central Nervous System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Italy Drugs for Central Nervous System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Russia Drugs for Central Nervous System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Drugs for Central Nervous System Sales Market Share by Region (2019-2030)
    Figure 32. Asia Pacific Drugs for Central Nervous System Revenue Market Share by Region (2019-2030)
    Figure 33. China Drugs for Central Nervous System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Japan Drugs for Central Nervous System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. South Korea Drugs for Central Nervous System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. India Drugs for Central Nervous System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Australia Drugs for Central Nervous System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. China Taiwan Drugs for Central Nervous System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Indonesia Drugs for Central Nervous System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Thailand Drugs for Central Nervous System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Malaysia Drugs for Central Nervous System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Latin America Drugs for Central Nervous System Sales Market Share by Country (2019-2030)
    Figure 43. Latin America Drugs for Central Nervous System Revenue Market Share by Country (2019-2030)
    Figure 44. Mexico Drugs for Central Nervous System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Brazil Drugs for Central Nervous System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Argentina Drugs for Central Nervous System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Middle East & Africa Drugs for Central Nervous System Sales Market Share by Country (2019-2030)
    Figure 48. Middle East & Africa Drugs for Central Nervous System Revenue Market Share by Country (2019-2030)
    Figure 49. Turkey Drugs for Central Nervous System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Saudi Arabia Drugs for Central Nervous System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. UAE Drugs for Central Nervous System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Global Sales Market Share of Drugs for Central Nervous System by Type (2019-2030)
    Figure 53. Global Revenue Market Share of Drugs for Central Nervous System by Type (2019-2030)
    Figure 54. Global Drugs for Central Nervous System Price (USD/Unit) by Type (2019-2030)
    Figure 55. Global Sales Market Share of Drugs for Central Nervous System by Application (2019-2030)
    Figure 56. Global Revenue Market Share of Drugs for Central Nervous System by Application (2019-2030)
    Figure 57. Global Drugs for Central Nervous System Price (USD/Unit) by Application (2019-2030)
    Figure 58. Drugs for Central Nervous System Value Chain
    Figure 59. Drugs for Central Nervous System Production Process
    Figure 60. Channels of Distribution (Direct Vs Distribution)
    Figure 61. Distributors Profiles
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Microcarrier Bioreactor Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-4O8609
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Immunohistochemistry Reagent Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-25I8231
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global RNA Analysis & Transcriptomic Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-2M4266
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global PCR Tubes And PCR Plates Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-38E8328
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions